Novel process for preparation of chondroitin fraction
AssigneeSeikagaku Corporation
InventorsNobuo Sugiura, Koji Kimata
Life of this patent
Estimating the term…
Loading patent…
AssigneeSeikagaku Corporation
InventorsNobuo Sugiura, Koji Kimata
Estimating the term…
Provided are a method for producing a fraction containing more than 50% of CH represented by the general formula (1), which comprises at least the step of allowing a glucuronic acid donor, an N-acetylgalactosamine donor, a saccharide receptor, a chondroitin polymerase derived from the Escherichia coli K4 strain, and Mn2+ at a final concentration of 0.02 to 100 mM to coexist, and performing a reaction thereof under conditions of 20 to 40° C. and pH 6 to 8 for 0.5 minutes to 4 hours, and a method for producing a fraction containing more than 50% of CH represented by the general formula (2), which comprises at least the step of performing the reaction under same conditions for 10 hours or longer, which enable industrial scale production of a CH fraction of a controlled even number saccharide and odd number saccharide content ratio by a simple procedure at a low cost. (GlcA-GalNAc)n (1) GalNAc-(GlcA-GalNAc)n (2) (In the formula, GlcA represents a glucuronic acid residue, GalNAc represents a N-acetylgalactosamine residue, - represents a glycosidic bond, and n represents an arbitrary integer.)
A method for producing a fraction comprising more than 50% of chondroitin represented by the general formula (1), which comprises the step of reacting a glucuronic acid donor, an N-acetylgalactosamine donor, a saccharide receptor, a chondroitin polymerase derived from the Escherichia coli K4 strain, and Mn2+ at a final concentration of 0.02 to 100 mM under conditions of 20 to 40° C. and pH 6 to 8 for 0.5 minutes to 4 hours,
A method for producing a fraction comprising chondroitin which comprises the step of reacting a glucuronic acid donor, an N-acetylgalactosamine donor, a saccharide receptor, a chondroitin polymerase derived from the Escherichia coli K4 strain, and Mn2+ at a final concentration of 0.02 to 100 mM under predetermined reaction conditions.
A method for producing a fraction comprising more than 50% of chondroitin represented by the general formula (2), which comprises the step of reacting a glucuronic acid donor, an N-acetylgalactosamine donor, a saccharide receptor, a chondroitin polymerase derived from the Escherichia coli K4 strain, and Mn2+ at a final concentration of 5 to 100 mM under conditions of 20 to 40° C. and pH 6 to 8 for 10 hours or longer.
14-16. (canceled)
A method according to claim 28, wherein the content ratio of ((1):(2)) is 45:55 to 55:45, the Mn2+ is present at a final concentration of 0.02 to 2 mM and reaction time is 5 hours or longer,
A method for producing a fraction comprising chondroitins represented by the general formulas (1) and (2) at a desired content ratio, which comprises the step of reacting a glucuronic acid donor and/or an N-acetylgalactosamine donor, a saccharide receptor, a chondroitin polymerase derived from the Escherichia coil K4 strain, and Mn2+ under conditions of 20 to 40° C. and pH 6 to 8,
Dependencies are inferred from the claim text.